David Nierengarten
Stock Analyst at Wedbush
(4.83)
# 428
Out of 4,442 analysts
546
Total ratings
50.4%
Success rate
19.1%
Average return
Main Sectors:
Stocks Rated by David Nierengarten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCRX TScan Therapeutics | Maintained: Buy | $5 | $0.921 | +442.89% | 6 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $135 | $132.88 | +1.60% | 14 | Jun 23, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $65 | $33.20 | +95.78% | 18 | Jun 22, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $80 → $100 | $97.05 | +3.04% | 9 | Jun 16, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $88 | $70.45 | +24.91% | 20 | Jun 16, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $35 | $22.94 | +52.57% | 3 | Jun 16, 2026 | |
| ODTX Odyssey Therapeutics | Maintained: Buy | $30 | $18.56 | +61.64% | 2 | Jun 16, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,000 | $853.40 | +17.18% | 56 | Jun 15, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $55 | $36.31 | +51.47% | 21 | Jun 15, 2026 | |
| NUVL Nuvalent | Downgraded: Hold | $125 → $124 | $123.44 | +0.45% | 12 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.00 | +266.67% | 13 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $110 → $90 | $98.43 | -8.56% | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $29.15 | +44.08% | 1 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $60 | $29.19 | +105.55% | 16 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 | $83.40 | +97.84% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $20.21 | +122.72% | 1 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $7.49 | +233.78% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $11 | $5.39 | +104.08% | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.04 | +82.12% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $59 | $59.49 | -0.82% | 21 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $59.43 | +26.20% | 33 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $8.91 | +124.47% | 22 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 69.00 | $33.82 | +104.02% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $9.80 | +134.69% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $35 | $28.76 | +21.70% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $18 | $14.13 | +27.39% | 14 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $14.08 | +84.66% | 14 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $14.85 | -46.13% | 11 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $25.00 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.16 | n/a | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $19.33 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $51.27 | n/a | 15 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $5.90 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $3.24 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $4 | $9.65 | n/a | 23 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $30.60 | n/a | 5 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $48 → $16 | $87.53 | n/a | 8 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $10.30 | n/a | 6 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $68 → $53 | $15.25 | n/a | 14 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $32 | $4.69 | n/a | 11 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €309.77 → €304.52 | $812.00 | n/a | 2 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $10 | $0.0001 | n/a | 3 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $36 | $3.70 | n/a | 7 | Jun 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $567.85 | n/a | 1 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $13 | $9.55 | n/a | 2 | Apr 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $10.38 | n/a | 1 | Dec 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.6998 | n/a | 1 | Nov 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $6.18 | n/a | 6 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $13 | $3.86 | n/a | 6 | Oct 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.0001 | n/a | 7 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.89 | n/a | 7 | Aug 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $32.98 | n/a | 3 | May 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $9 | $2.07 | n/a | 4 | Nov 17, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $102.15 | n/a | 3 | Mar 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.10 | n/a | 1 | Mar 22, 2013 |
TScan Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $5
Current: $0.921
Upside: +442.89%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $135
Current: $132.88
Upside: +1.60%
Beam Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $65
Current: $33.20
Upside: +95.78%
Spyre Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $80 → $100
Current: $97.05
Upside: +3.04%
Disc Medicine
Jun 16, 2026
Maintained: Buy
Price Target: $88
Current: $70.45
Upside: +24.91%
Damora Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $35
Current: $22.94
Upside: +52.57%
Odyssey Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $30
Current: $18.56
Upside: +61.64%
argenx SE
Jun 15, 2026
Maintained: Buy
Price Target: $1,000
Current: $853.40
Upside: +17.18%
Cogent Biosciences
Jun 15, 2026
Maintained: Buy
Price Target: $55
Current: $36.31
Upside: +51.47%
Nuvalent
Jun 10, 2026
Downgraded: Hold
Price Target: $125 → $124
Current: $123.44
Upside: +0.45%
Jun 4, 2026
Maintained: Buy
Price Target: $11
Current: $3.00
Upside: +266.67%
Jun 2, 2026
Upgraded: Hold
Price Target: $110 → $90
Current: $98.43
Upside: -8.56%
May 26, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $29.15
Upside: +44.08%
May 18, 2026
Upgraded: Buy
Price Target: $22 → $60
Current: $29.19
Upside: +105.55%
May 14, 2026
Maintained: Buy
Price Target: $165
Current: $83.40
Upside: +97.84%
May 14, 2026
Maintained: Buy
Price Target: $45
Current: $20.21
Upside: +122.72%
May 13, 2026
Maintained: Buy
Price Target: $25
Current: $7.49
Upside: +233.78%
May 8, 2026
Maintained: Buy
Price Target: $8 → $11
Current: $5.39
Upside: +104.08%
May 5, 2026
Maintained: Buy
Price Target: $11
Current: $6.04
Upside: +82.12%
Apr 29, 2026
Maintained: Buy
Price Target: $58 → $59
Current: $59.49
Upside: -0.82%
Mar 31, 2026
Reiterated: Buy
Price Target: $75
Current: $59.43
Upside: +26.20%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $8.91
Upside: +124.47%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: kr 69.00
Current: $33.82
Upside: +104.02%
Dec 18, 2025
Maintained: Buy
Price Target: $23
Current: $9.80
Upside: +134.69%
Oct 14, 2025
Maintained: Hold
Price Target: $75 → $35
Current: $28.76
Upside: +21.70%
Oct 13, 2025
Maintained: Hold
Price Target: $27 → $18
Current: $14.13
Upside: +27.39%
Sep 2, 2025
Maintained: Buy
Price Target: $26
Current: $14.08
Upside: +84.66%
Jun 26, 2025
Maintained: Hold
Price Target: $8
Current: $14.85
Upside: -46.13%
May 23, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $25.00
Upside: n/a
May 14, 2025
Maintained: Hold
Price Target: $5
Current: $2.16
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $33
Current: $19.33
Upside: n/a
Mar 17, 2025
Initiated Coverage: Buy
Price Target: $50
Current: $51.27
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $2
Current: $5.90
Upside: n/a
Apr 2, 2024
Initiated Coverage: Buy
Price Target: $12
Current: $3.24
Upside: n/a
Jul 26, 2023
Maintained: Hold
Price Target: $9 → $4
Current: $9.65
Upside: n/a
Jul 12, 2023
Downgraded: Hold
Price Target: $4 → $2
Current: $30.60
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: $48 → $16
Current: $87.53
Upside: n/a
Jan 25, 2023
Maintained: Buy
Price Target: $19 → $17
Current: $10.30
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $68 → $53
Current: $15.25
Upside: n/a
Jun 16, 2021
Maintained: Buy
Price Target: $34 → $32
Current: $4.69
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: €309.77 → €304.52
Current: $812.00
Upside: n/a
Aug 7, 2020
Maintained: Hold
Price Target: $9 → $10
Current: $0.0001
Upside: n/a
Jun 18, 2019
Maintained: Buy
Price Target: $19 → $36
Current: $3.70
Upside: n/a
Aug 16, 2018
Reiterated: Buy
Price Target: $95
Current: $567.85
Upside: n/a
Apr 23, 2018
Maintained: Hold
Price Target: $55 → $13
Current: $9.55
Upside: n/a
Dec 21, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $10.38
Upside: n/a
Nov 28, 2017
Initiated Coverage: Buy
Price Target: $20
Current: $0.6998
Upside: n/a
Oct 12, 2017
Reiterated: Buy
Price Target: $24 → $16
Current: $6.18
Upside: n/a
Oct 24, 2016
Reiterated: Hold
Price Target: $10 → $13
Current: $3.86
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.0001
Upside: n/a
Aug 3, 2016
Reiterated: Hold
Price Target: $2
Current: $0.89
Upside: n/a
May 9, 2016
Maintained: Hold
Price Target: $4 → $3
Current: $32.98
Upside: n/a
Nov 17, 2015
Reiterated: Buy
Price Target: $16 → $9
Current: $2.07
Upside: n/a
Mar 31, 2014
Maintained: Sell
Price Target: n/a
Current: $102.15
Upside: n/a
Mar 22, 2013
Reiterated: Hold
Price Target: n/a
Current: $20.10
Upside: n/a